证券简称：海利尔 证券代码：603639 海利尔药业集团股份有限公司 2025年限制性股票激励计划 （草案） 三、本激励计划拟授予激励对象的限制性股票数量为 1,250.00 万股，约占 本激励计划草案公布日公司股本总额 33,987.8336 万股的 3.68%。其中，首次 授予限制性股票 1,150.00 万股，约占本激励计划草案公布日公司股本总额 1 海利尔药业集团股份有限公司 二○二五年九月 声明 本公司及全体董事保证本激励计划及其摘要不存在虚假记载、误导性陈述或 重大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或行使权益安排的，激励对象应当自相关信 息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激励计划 所获得的全部利益返还公司。 特别提示 一、2025年限制性股票激励计划(以下简称"本激励计划"）是依据《中华 人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以 下简称《证券法》）、中国证券监督管理委员会《上市公司股权激励管理办法》 （以下简称"《 ...

2025 年限制性股票激励计划（草案）的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）接受海利尔药业集团 股份有限公司（以下简称海利尔或公司）委托，作为其实施 2025 年股票期权激励 计划（以下简称本激励计划、本次激励计划或本计划）的专项法律顾问，根据《中 华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简 称《证券法》）、中国证券监督管理委员会（以下简称中国证监会）《上市公司股权 激励管理办法》（以下简称《管理办法》）、《上海证券交易所股票上市规则》（以下 简称《上市规则》）、《上海证券交易所上市公司自律监管指南第 2 号——业务办理》 （以下简称《业务办理指南》）等法律、行政法规、部门规章及规范性文件（以下 简称法律法规）和《海利尔药业集团股份有限公司章程》（以下简称《公司章程》） 的有关规定，就公司实施本次激励计划所涉及的相关事项，出具本法律意见书。 为出具本法律意见书，金杜依据《律师事务所从事证券法律业务管理办法》和 《律师事务所证券法律业务执业规则（试行）》等有关规定，收集了相关证据材料， 查阅了按规定需要查阅的文件以及金 ...

海利尔（603639）(603639.SH)披露2025年限制性股票激励计划(草案)，拟授予激励对象的限制性股票数 量为1250万股，约占激励计划草案公布日公司股本总额的3.68%。其中，首次授予限制性股票1150万 股，首次授予激励对象共计618人，授予价格为7.28元/股。 ...

智通财经APP讯，海利尔(603639.SH)披露2025年限制性股票激励计划(草案)，拟授予激励对象的限制性 股票数量为1250万股，约占激励计划草案公布日公司股本总额的3.68%。其中，首次授予限制性股票 1150万股，首次授予激励对象共计618人，授予价格为7.28元/股。 ...

格隆汇9月29日｜海利尔公告，公司股东青岛合意投资中心（有限合伙）减持计划时间区间为2025年6月 27日至2025年9月26日，已通过集中竞价累计减持44.76万股，占公司总股本的0.1317%，减持价格区间 13.72～15.75元/股，套现632.78万元；其当前持股1720.46万股，占5.0620%。 ...

近日，中华人民共和国洋山海关发布关于海利尔药业集团股份有限公司违反海关监管规定行政处罚决定书（沪洋山关缉违字〔2025〕746号）。 经我关调查，当事人有以下违法行为：海利尔药业集团股份有限公司委托上海通域国际物流有限公司于2025年5月20日以一般贸易方式向海关申报出口3%苄 氨基嘌呤，3%赤霉酸A3可溶液剂14000千克至柬埔寨，货物毛重为19200千克，申报总价为CIF159800美元，申报商品编号为3808939190，报关单号 222920250001815066。经查，实际货物包括吡虫啉100g/L4200千克,商品编号3808911990；多抗霉素10g/L纳他霉素17g/L3300千克，商品编号3808921090；噻 虫嗪25%4000千克，商品编号3808911990；阿维菌素50g/L3150千克，商品编号3808911990；氰氟草酯300g/L2390千克，商品编号3808931190；溴虫腈100g/L 虱螨脲70g/L2160千克，商品编号3808911990。上述货物出口均需提交《农药进出口登记管理放行通知单》。 经计核，货物价值共计人民币1139833.84元。 上述事实业已 ...

Investment Rating - The industry investment rating is maintained as "Positive" [5] Core Viewpoints - The "Stabilizing Growth Work Plan" for the petrochemical industry has raised expectations, focusing on enhancing technological innovation, expanding effective investment, and fostering market demand [8] - The green low-carbon industry, particularly green polyester, is expected to experience rapid growth due to new technologies and significant market potential [8] Summary by Sections Investment Recommendations and Targets - The report favors companies that have strategically positioned themselves in the green polyester sector, such as Wankai New Materials (301216, Buy). Other recommended stocks include Sinopec (600028, Buy), Hengli Petrochemical (600346, Buy), Rongsheng Petrochemical (002493, Buy), Wanhua Chemical (600309, Buy), and Huayi Group (600623, Buy). Additionally, companies in the pesticide formulation segment like Runfeng Co., Ltd. (301035, Buy), Guoguang Co., Ltd. (002749, Buy), and Hailier (603639, Buy) are also highlighted [3] Industry Overview - The petrochemical industry is currently facing significant oversupply, making rapid recovery through market-driven policies challenging. However, the long-term outlook for the industry is improving, with lower valuations for leading chemical stocks providing good investment opportunities [8] - The green low-carbon sector, including green methanol, bio-aviation fuel, and green polyester, is gaining market attention due to its vast market space and the need for sustainable development. Companies that capitalize on these trends are expected to achieve rapid growth [8] Recent Developments - The recent "Stabilizing Growth Work Plan" emphasizes controlling new refining capacity and supporting key products in electronic chemicals and high-end polyolefins, while also fostering new application scenarios in emerging fields like renewable energy and low-altitude economy [8]

Core Viewpoint - The company has decided to cancel its supervisory board and amend its articles of association due to the disqualification of six incentive targets from the 2021 restricted stock incentive plan, leading to the repurchase and cancellation of 20,000 unvested restricted shares [1]. Group 1 - The company held its eighth meeting of the fifth board of directors on April 28, 2025, where the proposal to cancel the supervisory board was approved [1]. - The total share capital of the company will decrease from 339,898,336 shares to 339,878,336 shares, and the registered capital will change from 339,898,336 yuan to 339,878,336 yuan [1]. - The company has completed the business registration change and obtained a new business license from the Qingdao Administrative Approval Service Bureau [1]. Group 2 - The company is classified as a listed other joint-stock company, with its registered address in the Chengdong Industrial Park, Chengyang District, Qingdao [1]. - The company was established on December 1, 1999, and its business scope includes the production and sale of water-soluble fertilizers and pesticides, as well as various other services related to agriculture and technology [1].

Core Viewpoint - The company announced the cancellation of its supervisory board and the revision of related proposals due to the disqualification of six incentive targets from its 2021 restricted stock incentive plan, leading to the repurchase and cancellation of 20,000 unvested restricted shares [1] Summary by Relevant Sections - **Board Meeting Announcement** - The company will hold its fifth board meeting on April 28, 2025, to review the proposal regarding the cancellation of the supervisory board [1] - **Incentive Plan Adjustments** - Six incentive targets from the 2021 restricted stock incentive plan are no longer qualified, resulting in the need to repurchase and cancel 20,000 unvested restricted shares [1] - **Capital Changes** - The total share capital will decrease from 339,898,336 shares to 339,878,336 shares, and the registered capital will change from 339,898,336 yuan to 339,878,336 yuan [1] - **Business License Update** - The company has completed the business registration change procedures and received a new business license from the Qingdao Administrative Approval Service Bureau [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 海利尔药业集团股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召 开第五届董事会第八次会议，审议通过了《关于取消监事会并修订<公司章程> 的议案》，鉴于公司2021年限制性股票激励计划6名激励对象已不具备激励资格， 上述激励对象持有的已获授但未解锁部分限制性股票共 2 万股需要进行回购注 销，公司总股本 339,898,336 股将减少至 339,878,336 股，公司注册资本由原来 的 339,898,336 元变更为 339,878,336 元，相关内容详见公司于 2025 年 4 月 29 日在上海证券交易所网站（www.sse.com.cn）披露的《关于取消监事会并修订< 公司章程>的公告》（公告编号：2025-026）。 近日，公司完成了工商变更登记手续，并取得了青岛市行政审批服务局换发 的《营业执照》，具体内容如下： 统一社会信用代码：913702007180212494 证券代码：603639 证券简称：海利尔 公告编号：2025-045 海利尔 ...